SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818 | +5.8% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,718 | -16.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,067 | +6.3% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,944 | +17.2% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,658 | +47.5% | 15 | 0.0% | 0.00% | – |
| Q2 2022 | $1,124 | -4.1% | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $1,172 | -13.2% | 15 | 0.0% | 0.00% | – |
| Q4 2021 | $1,351 | -18.9% | 15 | -16.7% | 0.00% | -100.0% |
| Q3 2021 | $1,665 | +33.8% | 18 | +12.5% | 0.00% | – |
| Q2 2021 | $1,244 | +864.3% | 16 | +1500.0% | 0.00% | – |
| Q4 2019 | $129 | -95.2% | 1 | -97.2% | 0.00% | -100.0% |
| Q3 2019 | $2,712 | -50.4% | 36 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $5,470 | +27.5% | 36 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,291 | -70.0% | 36 | -72.5% | 0.00% | -66.7% |
| Q4 2018 | $14,296 | -32.4% | 131 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $21,158 | +22.2% | 131 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $17,316 | – | 131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |